Vaccitech

Description: Vaccitech, a Univ. of Oxford spin-out, develops viral vector vaccines for flu & prostate cancer, leveraging advanced adenovirus tech for strong immunity.

Country: UK

Based in: Oxford

Founded: 2016

Funding Stage: Series A/B

Tags: ['vaccine', 'immunity', 'health']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.